Nutritional management of maintenance dialysis patients: Why aren't we doing better?

Annual Review of Nutrition

Volumn 21, Issue , 2001, Pages 343-379

  Mehrotra, R ^a   Kopple, J D ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Anorexia; Chronic renal failure; Comorbidity; Inflammation; Protein energy malnutrition

Indexed keywords

LEPTIN;

ANOREXIA; CALORIC INTAKE; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; INFLAMMATION; MALNUTRITION; NUTRITION; NUTRITIONAL STATUS; PATIENT CARE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; REVIEW;

ANOREXIA; DIET; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; NUTRITION PHYSIOLOGY; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS;

GLOMERULUS;

EID: 0034941570     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.21.1.343     Document Type: Review

References (249)

1. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients
2. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters
3. Middle-sized uremic fractions from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat
4. Nutritional status of haemodialysis patients: A French national co-operative study
5. Total body nitrogen predicts long-term mortality in hemodialysis patients - A single center experience
6. Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic factors
7. Markers for survival in dialysis: A seven year prospective study
8. Effects of intraperitoneal infusion of dextrose and amino acids on the appetite of rats
9. Down-regulation of albumin synthesis in the rat by human recombinant interleukin-1 beta or turpentine and the response to nutrients
10. The acute phase response in patients receiving subcutaneous IL-6
11. Prediction of early death in end-stage renal disease patients starting dialysis
12. Herman Award Lecture 1995: Infection-induced malnutrition - From cholera to cytokines
13. Relationship between Kt/V and protein catabolic rate (PCR) is different in continuous peritoneal dialysis and hemodialysis patients
14. Protein and energy intake, nitrogen balance, and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis
15. Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in hemodialysis patients
16. The biology of cachectin/TNF - A primary mediator of host response
17. Plasma interleukin-1 activity during hemodialysis: The influence of dialysis membranes
18. Gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis
19. Serum albumin in patients on continuous ambulatory peritoneal dialysis - Predictors and correlations with outcomes
20. Lack of correlation between urea kinetic indices and clinical outcome
21. Methods for assessing nutritional status of patients with renal failure
22. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis
23. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
24. Nitrogen balance during intermittent dialysis therapy of uremia
25. Evidence for the presence of chronic inflammation during peritoneal dialysis: Therapeutic implications
26. Evidence for a peripheral signal linking adiposity and central neural networks
27. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
28. Protein catabolic rate over lean body mass ratio: A more rational approach to normalize the protein catabolic rate in dialysis patients
29. Statistical selection of nutritional parameters in hemodialyzed patients
30. Serum interleukin-6 in long-term hemodialyzed patients
31. Induction of tumor necrosis factor-alpha during hemodialysis. Influence of membrane type
32. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival
33. Canadian hemodialysis morbidity study
34. Cross-sectional comparisons of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients
35. Prediction of creatinine clearance from serum creatinine
36. Serum amyloid A-containing human high density lipoprotein 3 density size, and apolipoprotein composition
37. Urea index (Kt/V) and other predictors of hemodialysis patient survival
38. Modeling mortality risk in hemodialysis patients using laboratory values as time-dependent co-variates
39. Tumor necrosis factor does not increase during routine cuprophan hemodialysis in healthy well-nourished patients
40. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients
41. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival
42. Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane Collobarative Study
43. Balance between IL-1 beta, TNF alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells and monocytes
44. Mechanism of disease: Interleukin-1 and the pathogenesis of the acute phase response
45. Mechanisms of loss of lean body mass in patients on chronic dialysis
46. Elevated acute-phase reactants in hemodialysis patients
47. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients
48. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1
49. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients
50. The nutrition implications of cardiac cachexia
51. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients
52. Structure and expression of the rat trasnthyretin (prealbumin) gene
53. Nitrogen balance in hemodialysis patients
54. The effect of improved dialytic efficiencies on measures of appetite in peritoneal dialysis patients
55. Protein requirements of patients on CAPD: A study of nitrogen balance
56. Predictors of mortality in hemodialysis patients
57. Adequacy of dialysis and nutritional status in CAPD
58. Glucose absorption during continuous ambulatory peritoneal dialysis
59. Impaired gastric emptying in hemodialysis patients
60. Mechanisms of malnutrition in uremia
61. Muscle biopsy studies in chronically uremic patients: Evidence for malnutrition
62. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans
63. Weight reducing effects of the plasma protein encoded by the obese gene
64. Factors affecting low serum values of serum albumin in CAPD patients
65. Review of significant findings from the National Co-operative Dialysis study and recommendations
66. Limitations of urea kinetic models as predictors of nutritional and dialysis adequacy in continuous ambulatory peritoneal dialysis patients
67. The influence of small solute clearance on dietary protein intake in continuous ambulatory peritoneal dialysis patients: A methodologic analysis based on cross-sectional and prospective studies
68. Impact of increasing dialysis volume on adequacy targets: A prospective study
69. Energy metabolism during CAPD: A controlled study
70. Chronic induction of C-reactive protein by hemodialysis but not peritoneal dialysis therapy
71. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis (CAPD)
72. Albumin and aminoacid levels as markers of adequacy in continuous ambulatory peritoneal dialysis
73. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure
74. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of glucose
75. The hemodialysis (HEMO) pilot study: Nutrition program and participant characteristics at baseline
76. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha
77. Elevated circulating levels of interleukin-6 in patients with chronic renal failure
78. Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 beta levels and different dialysis membranes
79. Plasma immunoreactive leptin concentration in end stage renal disease
80. Oxidized LDL induces enhanced antibody formation and MCH class II-dependent INF-gamma production in lymphocytes from healthy individuals
81. Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients
82. Changes in patients' eating behavior: In the uremic state, on continuous ambulatory peritoneal dialysis, and after transplantation
83. Spontaneous dietary and protein intake during progression of chronic renal failure
84. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
85. Increased energy expenditure in hemodialysis patients
86. The effect of long, slow haemodialysis on patient survival
87. Serum albumin is a strong predictor of death in chronic dialysis patients
88. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
89. Impact of the initial levels of laboratory variables on survival in chronic dialysis patients
90. IGF-1, a marker of undernutrition in hemodialysis patients
91. The acute-phase response to turpentine-induced abscess in malnourished rats at different environmental temperatures
92. Leptin, body composition and indices of malnutrition in patients on dialysis
93. Human monocytes/macrophages release TNF alpha in response to oxidized LDL
94. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
95. Delayed gastric emptying in patients with chronic renal failure
96. High lipoprotein(a) levels in chronic hemodialysis patients are closely related to the acute-phase reaction
97. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
98. Mechanisms of hypoalbuminemia in hemodialysis patients
99. Determinants of albumin concentration in hemodialysis patients
100. Influence of comorbidity on mortality and morbidity in patients treated with hemodialysis
101. The effect of dialysate dwell on gastric emptying time in patients on continuous ambulatory peritoneal dialysis
102. Serum IL-6 as an indicator of survival outcome in CAPD patients
103. Tumor necrosis factor alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes
104. Relating protein intake to nutritional status in hemodialysis patients: How to normalize the protein equivalent of total nitrogen appearance
105. Transient impact of hemodialysis on gastric myoelectrical activity of uremic patients
106. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: A prospective study in 412 subjects
107. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients
108. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro
109. Nutritional status of patients with differing levels of chronic renal insufficiency
110. Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure
111. Optimal dietary protein treatment during chronic hemodialysis
112. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients
113. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients
114. Lipoprotein(a) in renal disease
115. Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxin (LPS)
116. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients
117. Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients
118. Effect of dialysis modalities on gastric myoelectrical activity in end-stage renal disease patients
119. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation
120. Protective adaptation of low serum triiodothyronine in patients with chronic renal failure
121. Protein metabolism in patients with chronic renal failure: Role of uremia and dialysis
122. Which comes first, Kt/V or PCR - Chicken or egg?
123. A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic subjects
124. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes
125. Caloric rather than protein deficiency predominates in stable chronic hemodialysis patients
126. Oxidative stress in haemodialysis
127. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
128. Race and diabetes as death risk predictors in hemodialysis patients
129. The relevance of urea kinetic modeling to CAPD
130. Transient changes of serum lipoprotein (a) as an acute phase protein
131. The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients
132. Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients
133. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease
134. Serum albumin in continuous ambulatory peritoneal dialysis: Its predictors and relationship to urea clearance
135. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
136. Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats
137. Evidence of splanchnic-brain signaling in inhibition of ingestive behavior by middle molecules
138. The impact of malnutrition in morbidity and mortality in stable hemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis
139. Serum albumin: Associations and significance in peritoneal dialysis patients
140. Middle molecule clearance does not influence protein intake in hemodialysis patients
141. Protein intake seems to respond to increases in Kt/V despite baseline Kt/V greater than 1.2
142. How much peritoneal dialysis is necessary for maintaining a good nutritional status?
143. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
144. Nightly home hemodialysis: Improvement in nutrition and quality of life
145. Increase in serum albumin upon initiation of maintenance hemodialysis: Evidence for improvement in nutritional status?
146. Argument for timely initiation of dialysis
147. Towards targets for initiation of chronic dialysis
148. Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients
149. Increased plasma leptin concentration in end-stage renal disease
150. Role of kidney in human leptin metabolism
151. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
152. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study
153. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: Interactions and therapeutic options
154. Energy expenditure in patients with chronic renal failure
155. Cytokines and the hepatic acute phase response
156. Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation
157. Influence of protein catabolic rate on nutritional status, morbidity and mortality in elderly uraemic patients on chronic hemodialysis: A prospective 3-year follow-up study
158. Effect of age on protein catabolic rate, morbidity and mortality in ureamic patients with adequate dialysis
159. Interleukin-8 in chronic renal failure and dialysis patients
160. Clinical practice guidelines for nutrition in chronic renal failure
161. The yin and yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture
162. Anthropometric norms for the dialysis population
163. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
164. Plasma leptin level and its relationship between body composition in hemodialysis patients
165. Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients
166. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis
167. Prevalence and factors associated with sub optimal care before initiation of dialysis in United States
168. Association of the serum leptin concentration with weight loss in chronic hemodialysis patients
169. Measurement of resting energy expenditure via indirect calorimetery during adult hemodialysis treatment
170. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: A pilot study
171. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing maintenance hemodialysis
172. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
173. Cross-sectional assessment of nutritional and immune status in renal patients undergoing continuous ambulatory peritoneal dialysis
174. Serum paraxonase activity changes in uremic and kidney transplanted patients
175. Protein intake and nutritional status in patients with predialysis chronic renal failure on unrestricted diet
176. A cross-sectional study comparing the nutritional status of peritoneal dialysis and hemodialysis patients
177. Comparison of the study groups in the national cooperative dialysis study and a description of morbidity, mortality and patient withdrawal
178. Effect of membrane biocompatibility on nutritional parameters in chronic hemodialysis patients
179. Effect of the obese gene product on body weight regulation in ob/ob mice
180. Plasma levels of IL-1 beta, TNF alpha, and their specific inhibitors in undialyzed patients with chronic renal failure
181. High creatinine excretion ratio predicts a good outcome in peritoneal dialysis patients
182. Nocturnal hemodialysis: Three year experience
183. Total body nitrogen by neutron activation analysis in maintenance dialysis patients
184. Total body nitrogen as a prognostic marker in maintenance dialysis
185. Protein intake in renal disease
186. Lack of elevation of plasma interleukin-1 beta or tumor necrosis alpha during unfavorable hemodialysis conditions
187. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
188. Calculated nitrogen balance in hemodialysis patients: Influence of protein intake
189. Anthropometry underestimates body protein depletion in hemodialysis patients
190. CAPD adequacy data in a national cohort sample: The 1999 health care financing administration (HCFA) ESRD Peritoneal Dialysis Clinical Performance Measures (PD-CPM)
191. The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients
192. Improved nutrition after detection and treatment of occult gastroparesis in nondiabetic dialysis patients
193. Atherosclerosis - An inflammatory disease
194. Rheumatoid cachexia: Cytokine driven hypercatabolism accompanying reduced body cell mass in chronic inflammation
195. Lipoproteins and acute-phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid A protein lipoproteins
196. Longitudinal evaluation of renal Kt/Vurea of 2.0 as a threshold for initiation of dialysis
197. Urea kinetics: A guide to nutritional management of renal failure
198. Nutritional status of patients on long-term CAPD
199. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement
200. Energy metabolism in acute and chronic renal failure
201. Assessment of nutritional status of the national co-operative dialysis study population
202. Effect of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized controlled clinical trial
203. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients
204. Limitations of creatinine as a filtration marker in glomerulopathic patients
205. Effect of energy intake on nutritional status in maintenance hemodialysis patients
206. Gastric emptying in chronic renal failure patients on hemodialysis
207. Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients
208. The major acute-phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
209. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
210. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
211. High serum hyaluronan indicates poor survival in renal replacement therapy
212. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass
213. The effect of computerized dietary analysis nutrition education on nutrition knowledge, nutritional status, dietary compliance, and quality of life of hemodialysis patients
214. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival
215. Effects of recombinant growth factors on energy expenditure in maintenance hemodialysis patients
216. Protein nutritional status of adult patients starting chronic ambulatory peritoneal dialysis
217. Effect of biocompatibility of hemodialysis membranes on serum albumin levels
218. Urea kinetic analysis and clinical outcome in CAPD: A five-year longitudinal study
219. Effects of ultrapure dialysate and non-sterile dialysate on the inflammatory response during in vitro hemodialysis
220. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1 and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
221. Hemodialysis and the acute-phase response in chronic uremic patients
222. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice
223. Another look at the relationship between protein intake and dialysis dose
224. Comorbid conditions and correlations with mortality among 3,399 incident hemodialysis patients
225. Caloric intake in a group of peritoneal dialysis patients
226. Lp(a) glycoprotein phenotypes; inheritance and relation to Lp(a)-lipoprotein concentrations in plasma
227. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease
228. Genetic influences on lipoprotein(a) concentrations
229. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients
230. Body composition, treatment time, and outcome in hemodialysis
231. Catabolic illness - Strategies for enhancing recovery
232. Hypocholesterolemia in patients treated with interleukin-2: Appearance of remnant-like lipoproteins
233. Body size, dose of dialysis and mortality
234. Nutritional status and lymphocyte function in maintenance hemodialysis patients
235. Whole body and regional body composition in patients with chronic renal failure
236. Gastric emptying in patients with chronic renal failure receiving hemodialysis
237. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
238. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
239. Nutritional assessment of continuous ambulatory peritoneal dialysis patients
240. Increased plasma leptin/fat ratio in patients with chronic renal failure: A cause for malnutrition?
241. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients